In clinical studies of IPF, researchers found that plasma levels of sPD-L1 were significantly higher in IPF patients than in healthy controls, and that sPD-L1 levels tended to increase with the progression of fibrosis (162, 163). Here, SPDL1 is linked to idiopathic pulmonary fibrosis.